OPTN/SRTR 2020 Annual Data Report: Lung

M. Valapour; C. J. Lehr; M. A. Skeans; J. M. Smith; E. Miller; R. Goff; T. Mupfudze; K. Gauntt; J. J. Snyder

doi:10.1111/ajt.16991

OPTN/SRTR 2020 Annual Data Report: Lung

M. Valapour, C. J. Lehr, M. A. Skeans, J. M. Smith, E. Miller, R. Goff, T. Mupfudze, K. Gauntt, J. J. Snyder

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Abstract

For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.

Original language	English (US)
Pages (from-to)	438-518
Number of pages	81
Journal	American Journal of Transplantation
Volume	22
Issue number	S2
DOIs	https://doi.org/10.1111/ajt.16991
State	Published - Mar 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
© John Wiley & Sons, Ltd.

Keywords

End-stage lung disease
LAS
lung allocation score
lung transplant
organ allocation
revised lung allocation score
transplant outcomes

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1111/ajt.16991

OpenUrl availability

Full text

Cite this

@article{867253a50b4546258e66c3f96f8a587a,

title = "OPTN/SRTR 2020 Annual Data Report: Lung",

abstract = "For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.",

keywords = "End-stage lung disease, LAS, lung allocation score, lung transplant, organ allocation, revised lung allocation score, transplant outcomes",

author = "M. Valapour and Lehr, {C. J.} and Skeans, {M. A.} and Smith, {J. M.} and E. Miller and R. Goff and T. Mupfudze and K. Gauntt and Snyder, {J. J.}",

note = "Publisher Copyright: {\textcopyright} John Wiley & Sons, Ltd.",

year = "2022",

month = mar,

doi = "10.1111/ajt.16991",

language = "English (US)",

volume = "22",

pages = "438--518",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Wiley-Blackwell",

number = "S2",

}

TY - JOUR

T1 - OPTN/SRTR 2020 Annual Data Report

T2 - Lung

AU - Valapour, M.

AU - Lehr, C. J.

AU - Skeans, M. A.

AU - Smith, J. M.

AU - Miller, E.

AU - Goff, R.

AU - Mupfudze, T.

AU - Gauntt, K.

AU - Snyder, J. J.

N1 - Publisher Copyright: © John Wiley & Sons, Ltd.

PY - 2022/3

Y1 - 2022/3

N2 - For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.

AB - For the first time in a decade, both the number of candidates added to the waiting list and the number of lung transplants performed decreased from the year prior; the number of lung donors also declined. This slowing of transplant activities in 2020 was associated with a modest increase in waitlist mortality. The year 2020 was notable for the global outbreak of the COVID-19 pandemic, which undoubtedly influenced all trends noted in lung transplantation. Time to transplant continued to decrease, with a median time to transplant of 1.4 months across all waitlist candidates. Posttransplant survival remained stable, with 89.4% of transplant recipients surviving to 1 year, 74.8% to 3 years, and 61.2% to 5 years.

KW - End-stage lung disease

KW - LAS

KW - lung allocation score

KW - lung transplant

KW - organ allocation

KW - revised lung allocation score

KW - transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=85126077754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126077754&partnerID=8YFLogxK

U2 - 10.1111/ajt.16991

DO - 10.1111/ajt.16991

M3 - Article

C2 - 35266615

AN - SCOPUS:85126077754

SN - 1600-6135

VL - 22

SP - 438

EP - 518

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - S2

ER -

OPTN/SRTR 2020 Annual Data Report: Lung

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this